Dose Separation Does Not Overcome the Pharmacokinetic Interaction between Fosamprenavir and Lopinavir/Ritonavir
Amanda Corbett(University of North Carolina at Chapel Hill), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill), Michael L. Lim(GlaxoSmithKline (United Kingdom)), Hsiao‐Chuan Tien, Linh Ngô(AIDS United), Kristine B. Patterson(University of North Carolina at Chapel Hill), Leslie A. Kalvass(University of North Carolina at Chapel Hill)
Cited by 9
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k